Pre-earnings options volume in BioMarin is 7.0x normal with puts leading calls 19:6. Implied volatility suggests the market is anticipating a move near 5.4%, or $4.99, after results are released. Median move over the past eight quarters is 3.2%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRN:
- BioMarin price target raised to $110 from $100 at Cantor Fitzgerald
- Biomarin Pharmaceutical Inc. (BMRN) Q1 Earnings Cheat Sheet
- BioMarin participates in a conference call with JPMorgan.
- BioMarin presents new data for Voxzogo in achondroplasia and achondroplasia
- Fly Insider : Echostar, Dell among week’s notable insider trades
